ALLO

Allogene Therapeutics Inc

NASDAQ · Biotechnology

$1.69

+0.06 (+3.68%)

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

20 analysts

Buy 16 80%

Hold 3 15%

Sell 1 5%

Price Target

Analyst Price Target +1,202.4% upside

Low Target $17.29

Average Target $22.01

High Target $30.07

Current Price $1.69

Current
$1.69

Target
$22.01

$17.29 $22.01 avg $30.07